The role of calcium channel blockers in the treatment of hypertension
- 1 February 1986
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 111 (2) , 363-382
- https://doi.org/10.1016/0002-8703(86)90154-7
Abstract
No abstract availableThis publication has 114 references indexed in Scilit:
- Hypotension after Quinidine plus VerapamilNew England Journal of Medicine, 1985
- Diltiazem in the Treatment of Mild or Moderate Essential Hypertension. Comparison with Metoprolol in a Crossover Double‐Blind TrialThe Journal of Clinical Pharmacology, 1984
- Correlation of Platelet Calcium with Blood PressureNew England Journal of Medicine, 1984
- The effect of nifedipine on arterial pressure and reflex cardiac control.Circulation, 1983
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man.Circulation, 1982
- The effects of intravenous verapamil on hemodynamic status of patients with coronary artery disease receiving propranolol.Circulation, 1982
- β-Adrenoceptor Antagonists: New Drugs and New IndicationsNew England Journal of Medicine, 1981
- Verapamil-Digoxin InteractionNew England Journal of Medicine, 1980
- Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension.Circulation, 1980